Filed in archive
Drugs, Vaccines and Therapeutics
by ruth on April 18, 2006
Daytrana is a once-daily patch for children ages 6 to 12 that is supposed to be applied early in the morning and removed nine hours later. It should be worn on the hip, alternating left and right sides every day, and comes in four strengths.
There have been concerns raised regarding safety, Dosage and the possibility of abuse, considering that the active ingredient, methylphenidate, is one of the most commonly abused drugs among young people. FDA officials say, however, the patch passed clinical trials, and the manufacturers, Shire Pharmaceuticals Group PLC and Noven Pharmaceuticals Inc., are going to monitor possible misuse. They also emphasize that the patch should be used as a part of a comprehensive ADHD treatment program which includes educational and social aspects.
Washington Post has more about the ADHD patch.
Permalink: FDA Approves ADHD Skin Patch
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/20302
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for FDA Approves ADHD Skin Patch:
|
Rating: 8.80 out of 5 vote(s) cast.
|
Response from:
ThePharmVoice
According to the results of a Phase IIIb clinical trial, Shire plc’s methylphenidate transdermal system (MTS), DAYTRANA™, is significantly efficient in reducing the symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in children age...
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
